Journals / The Journal of Pediatric Research / 2020 / Cilt: 7 - Sayı: 2

Clinical Features of COVID-19 in Children

Pages
88–91
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In particular, clinicians should test those children who have a history of family cluster even though they areasymptomatic or present with mild symptoms.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In early December, pneumonia cases of unknown origin started to appear and, on the 7th of January 2020, these cases were declared to be causedby a novel beta-coronavirus according to viral genome sequencing on the 11th of February, 2020.
📊
Key Findings & Data:Asof the end of April 2020, 122,392 laboratory-confirmed cases of COVID-19 had been detected in Turkey, of whom 3,258 died.
💡
Conclusion & Impact:In particular, clinicians should test those children who have a history of family cluster even though they areasymptomatic or present with mild symptoms.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Özet

In early December, pneumonia cases of unknown origin started to appear and, on the 7th of January 2020, these cases were declared to be causedby a novel beta-coronavirus according to viral genome sequencing on the 11th of February, 2020. Coronaviruses are enveloped, single strand RNAviruses that have been known to have the ability to mutate rapidly, alter tissue tropism and adjust to different epidemiological situations. Asof the end of April 2020, 122,392 laboratory-confirmed cases of COVID-19 had been detected in Turkey, of whom 3,258 died. From the beginningof the COVID-19 epidemic, children seem to be less affected than adults. Therefore, there are limited data regarding the clinical features ofCOVID-19 in children. The majority of children with confirmed COVID-19 had a history of household contact. The most common symptoms werefever and cough. Previous data suggest that nearly half of patients are afebrile at the onset of the disease. Hospitalization and PICU admissionrates for children were lower than for adults. However, PICU admission can be necessitated in children with severe disease. Infants, particularlyunder the age of 12 months, were more likely to develop severe disease. In children, milder and asymptomatic cases can be challenging andcan play a role in transmission. In particular, clinicians should test those children who have a history of family cluster even though they areasymptomatic or present with mild symptoms.

🔖

Cite This Article

BAL, Z. Ş., KURUGÖL, Z., OZKINAY, F. (2020). Clinical Features of COVID-19 in Children. The Journal of Pediatric Research, Cilt: 7 - Sayı: 2, 88–91. https://ajindex.com/articles/362738

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Zhu N, Zhang D, Wang W, et al. China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020;382:727-33
  2. World Health Organization. WHO Director-general’s remarks at the media briefing on 2019-nCoV on 11 February 2020, 2020. Available at: https://www.who.int/dg/speeches/detail/whodirector- general-s-remarks-at-the-media-briefing-on-2019- ncov-on-11-february-2020. Accessed 11 February 2020
  3. Gorbalenya AE, Baker SC, Baric RS, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019- nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536-44
  4. World Health Organization (WHO). WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. Geneva: 11 Mar 2020. Available from: https://www. who.int/dg/speeches/detail/who-director-general-s-openingremarks- at-the-media-briefing-on-covid-19---11-march-2020
  5. Türkiye Cumhuriyeti Sağlık Bakanlığı.https://covid19.saglik.gov. tr/Accessed at May1,2020
  6. Helmy YA, Fawzy M, Elaswad A, Sobieh A, Kenney SP, Shehata AA. The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control. J Clin Med 2020;9
  7. Jin Y, Yang H, Ji W, et al. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses 2020;12
  8. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565-74
  9. Cevik M, Bamford C, Ho A. COVID-19 pandemic - A focused review for clinicians. Clin Microbiol Infect. 2020 Apr 25
  10. Bassetti M, Vena A, Giacobbe DR. The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm. Eur J Clin Invest 2020;50:e13209
  11. Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020 Mar 16. pii: e20200702
  12. CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children – United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep 2020;69:422-26
  13. Lu X, Zhang L, Du H, et al. Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 Infection in Children. N Engl J Med 2020 Mar 18
  14. Zheng F, Liao C, Fan QH, et al. Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China. Curr Med Sci 2020 Mar 24
  15. Parri N, Lenge M, Buonsenso D. Coronavirus Infection in Pediatric Emergency Departments (CONFIDENCE) Research G